Xueming Qian

Title: Xueming Qian: Innovator in Anti-PD-L1 Antibodies

Introduction

Xueming Qian is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-PD-L1 antibodies. With a total of 2 patents, his work is paving the way for advancements in therapeutic treatments.

Latest Patents

Xueming Qian's latest patents focus on isolated PD-L1 antibodies. These antibodies exhibit a unique characteristic where their binding to PD-L1 at acidic pH is substantially lower than at neutral pH under the same assay conditions. Additionally, he has developed an isolated PD-L1 antibody that is not pH dependent in its binding to PD-L1. His patents also include pharmaceutical compositions of these antibodies, encoding polynucleotides, expression vectors, and isolated host cells. Furthermore, methods for treating PD-L1 associated conditions using these antibodies are also provided.

Career Highlights

Throughout his career, Xueming Qian has worked with various companies, including Suzhou Transcenta Therapeutics Co., Ltd. His expertise in the field has allowed him to contribute to innovative solutions in biotechnology.

Collaborations

Xueming has collaborated with notable coworkers such as Teng Fei and Zhen Li, enhancing the impact of his research and development efforts.

Conclusion

Xueming Qian's contributions to the field of anti-PD-L1 antibodies demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a key figure in biotechnology.